These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2462300)

  • 1. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy.
    Caine M
    Urology; 1988 Dec; 32(6 Suppl):16-20. PubMed ID: 2462300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha adrenergic antagonists for the treatment of symptomatic BPH.
    Lepor H
    Int J Clin Pharmacol Ther Toxicol; 1989 Apr; 27(4):151-5. PubMed ID: 2469658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory assessment of terazosin and alpha-1 blockade in prostatic hyperplasia.
    Lepor H; Gup DI; Baumann M; Shapiro E
    Urology; 1988 Dec; 32(6 Suppl):21-6. PubMed ID: 2462301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
    Caine M
    Urol Clin North Am; 1990 Aug; 17(3):641-9. PubMed ID: 1695784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of alpha blockers in the treatment of BPH: a critical review of clinical results.
    Von Heland M; Casale P
    Arch Esp Urol; 1994 Nov; 47(9):873-81; discussion 881-2. PubMed ID: 7530943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
    Bouffioux CR; Penders L
    Eur Urol; 1984; 10(5):306-10. PubMed ID: 6083868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic alpha adrenoceptors.
    Lepor H; Shapiro E
    Prog Clin Biol Res; 1994; 386():271-7. PubMed ID: 7528394
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical management of benign prostatic hyperplasia: a review.
    Magoha GA
    East Afr Med J; 1996 Jul; 73(7):453-6. PubMed ID: 8918007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alpha 1-blockade in benign prostatic hyperplasia.
    Brawer MK
    J Clin Pharmacol; 1993 Sep; 33(9):891-5. PubMed ID: 7693769
    [No Abstract]   [Full Text] [Related]  

  • 12. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality?
    Tahmatzopoulos A; Kyprianou N
    Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha blocker prazosin for the treatment of benign prostatic hypertrophy (BPH).
    Punekar SV; Kelkar AR; Gavande PM; Rao NR; Date JA; Prem AR
    J Postgrad Med; 1995; 41(4):99-101. PubMed ID: 10707729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alpha blockers in the treatment of benign hyperplasia of the prostate].
    Gómez Sancha F; Fernández Arjona M; Peinado Ibarra F; Fernández Borrell A; Mínguez Martínez R; Pereira Sanz I
    Rev Clin Esp; 1997 May; 197(5):358-62. PubMed ID: 9280971
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience: symptomatic management of BPH with terazosin.
    Dunzendorfer U
    Urology; 1988 Dec; 32(6 Suppl):27-31. PubMed ID: 2462302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Embryologic development of the prostate. Insights into the etiology and treatment of benign prostatic hyperplasia.
    Shapiro E
    Urol Clin North Am; 1990 Aug; 17(3):487-93. PubMed ID: 1695777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the alpha-adrenoceptor characteristics in human and canine prostate.
    Hieble JP; Boyce AJ; Caine M
    Fed Proc; 1986 Oct; 45(11):2609-14. PubMed ID: 2428671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study.
    Dunzendorfer U
    Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.